{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:40:49Z","timestamp":1761864049690,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nefro.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T18:28:22Z","timestamp":1576175302000},"page":"320-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u00cdndices plaquetas-linfocito y neutr\u00f3filo-linfocito como marcadores de resistencia a la eritropoyetina en pacientes en hemodi\u00e1lisis cr\u00f3nica: estudio transversal-multic\u00e9ntrico"],"prefix":"10.1016","volume":"40","author":[{"given":"Francisco","family":"Valga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Santana-del-Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Ant\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2019.09.007_bib0165","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"Tuegel","year":"2017","journal-title":"Heart."},{"key":"10.1016\/j.nefro.2019.09.007_bib0170","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-017-3721-5","article-title":"Health-related quality of life of children with pre-dialysis chronic kidney disease","volume":"32","author":"Baek","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11739-017-1637-5","article-title":"Anemia is a mortality prognostic factor in patients initially hospitalized for acute heart failure","volume":"12","author":"Migone de Amicis","year":"2017","journal-title":"Intern Emerg Med."},{"key":"10.1016\/j.nefro.2019.09.007_bib0180","first-page":"343","article-title":"Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease","volume":"32","author":"Guerrero-Riscos","year":"2012","journal-title":"Nefrologia."},{"issue":"Suppl. 69","key":"10.1016\/j.nefro.2019.09.007_bib0185","first-page":"20","article-title":"[Clinical management of anemia in patients with CKD]","volume":"34","author":"Rivera","year":"2017","journal-title":"G Ital Nefrol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nefro.2015.10.018","article-title":"The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects","volume":"36","author":"Mart\u00ednez-Urbistondo","year":"2016","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2019.09.007_bib0195","first-page":"692","article-title":"Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13","volume":"32","author":"Birnie","year":"2017","journal-title":"Nephrol Dial Transplant."},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2019.09.007_bib0200","first-page":"25","article-title":"[Managing anaemia in kidney transplant patients with chronic kidney disease]","volume":"29","author":"Lopez Oliva","year":"2009","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2019.09.007_bib0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000442280","article-title":"The impact of lowering haemoglobin targets on patterns of erythropoiesis-stimulating agent use in patients on haemodialysis","volume":"41","author":"Hazara","year":"2016","journal-title":"Blood Purif."},{"issue":"Supl. 3","key":"10.1016\/j.nefro.2019.09.007_bib0210","first-page":"4","article-title":"Resistencia al tratamiento con eritropoyetina","volume":"19","author":"L\u00f3pez-G\u00f3mez","year":"1999","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2019.09.007_bib0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1744-9987.12380","article-title":"The predictive value of platelet\/lymphocyte ratio in hemodialysis patients with erythropoietin resistance","volume":"20","author":"Taymez","year":"2016","journal-title":"Ther Apher Dial."},{"key":"10.1016\/j.nefro.2019.09.007_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40620-014-0121-9","article-title":"Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study","volume":"28","author":"Eriguchi","year":"2015","journal-title":"J Nephrol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000358215","article-title":"Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients","volume":"37","author":"Okazaki","year":"2014","journal-title":"Blood Purif."},{"issue":"Suppl. 5","key":"10.1016\/j.nefro.2019.09.007_bib0230","first-page":"25","article-title":"Guideline 14: Causes of an inadequate response to epoetin treatmen","volume":"14","year":"1999","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2019.09.007_bib0235","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1038\/ki.2008.523","article-title":"Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality","author":"Lopez-Gomez","year":"2008","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.nefro.2019.09.007_bib0240","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/01.ASN.0000137879.97445.6E","article-title":"Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance","volume":"15","author":"Lopez-Gomez","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0245","doi-asserted-by":"crossref","first-page":"e0147328","DOI":"10.1371\/journal.pone.0147328","article-title":"ESA Hyporesponsiveness is associated with adverse events in maintenance hemodialysis (MHD) patients, but not with iron storage","volume":"11","author":"Kuragano","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2019.09.007_bib0250","first-page":"606","article-title":"[Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?]","volume":"21","author":"Perez-Garcia","year":"2001","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2019.09.007_bib0255","first-page":"555","article-title":"[Anemia management in haemodialysis. EuCliD database in Spain]","volume":"22","author":"Aviles","year":"2002","journal-title":"Nefrologia."},{"issue":"Supl. 4","key":"10.1016\/j.nefro.2019.09.007_bib0260","first-page":"1","article-title":"[Guidelines of the Spanish Society of Nephrology. Clinical practice guidelines for peritoneal dialysis]","volume":"26","author":"Arrieta","year":"2006","journal-title":"Nefrologia."},{"issue":"Supl. 8","key":"10.1016\/j.nefro.2019.09.007_bib0265","first-page":"1","article-title":"[Hemodialysis centers guides]","volume":"26","author":"Otero Gonzalez","year":"2006","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2019.09.007_bib0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/0886022X.2015.1104990","article-title":"Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients","volume":"38","author":"Neuen","year":"2016","journal-title":"Renal Fail."},{"key":"10.1016\/j.nefro.2019.09.007_bib0275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.amjcard.2008.05.006","article-title":"Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome","volume":"102","author":"Tamhane","year":"2008","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0280","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjcard.2012.11.012","article-title":"Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"111","author":"Park","year":"2013","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/hdi.12040","article-title":"Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients","volume":"17","author":"Turkmen","year":"2013","journal-title":"Hemodial Int."},{"key":"10.1016\/j.nefro.2019.09.007_bib0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0971-4065.107195","article-title":"Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease","volume":"23","author":"Turkmen","year":"2013","journal-title":"Indian J Nephrol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0295","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/0003-4819-122-5-199503010-00003","article-title":"Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction","volume":"122","author":"Thomson","year":"1995","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefro.2019.09.007_bib0300","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0002-9149(96)00878-8","article-title":"Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease","volume":"79","author":"Ommen","year":"1997","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.nefro.2019.09.007_bib0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2011.1.51","article-title":"The role of platelets in atherothrombosis","volume":"2011","author":"Kaplan","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.nefro.2019.09.007_bib0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tcm.2003.09.007","article-title":"Role of platelets in the development of atherosclerosis","volume":"14","author":"Huo","year":"2004","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.nefro.2019.09.007_bib0315","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ Res."},{"key":"10.1016\/j.nefro.2019.09.007_bib0320","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117735563","article-title":"Association of neutrophil-to-lymphocyte ratio with inflammation and erythropoietin resistance in chronic dialysis patients","volume":"4","author":"Pineault","year":"2017","journal-title":"Can J Kidney Health Dis."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:55:08Z","timestamp":1759323308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519301882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0211699519301882"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2019.09.007","relation":{},"ISSN":["0211-6995"],"issn-type":[{"type":"print","value":"0211-6995"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00cdndices plaquetas-linfocito y neutr\u00f3filo-linfocito como marcadores de resistencia a la eritropoyetina en pacientes en hemodi\u00e1lisis cr\u00f3nica: estudio transversal-multic\u00e9ntrico","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}